HEALTHPEAK PROPERTIES, INC. - Common Stock, $1.00 par value (DOC)

CUSIP: 42250P103

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class
Equity / Common Stock, $1.00 par value
Total 13F shares
544,075
Total 13F value
$11,643,461
Holder snapshot 6 signals
Share change
-51,723
SEC-reported price per share
$21.40
Number of holders
17
Value change
-$1,106,933
Number of buys
6
Number of sells
6
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
706,450,377

Security key

42250P103

Report period

Q2 2026

Institutions

17

Top holders

10

DOC full security history Ownership snapshot Full 13F holder table Previous quarter: Q1 2026 HEALTHPEAK PROPERTIES, INC. SEC filings HEALTHPEAK PROPERTIES, INC. company facts HEALTHPEAK PROPERTIES, INC. 13D/G history

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of DOC - HEALTHPEAK PROPERTIES, INC. - Common Stock, $1.00 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
29 May 2026
13D/G 13F 3/4/5 Lead comparable stake: 10% 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock, Inc. 10%
VANGUARD PORTFOLIO MANAGEMENT LLC 8.4%
VANGUARD CAPITAL MANAGEMENT LLC 7.4%
JPMORGAN CHASE & CO 6.1%
Thomas John T. 0.12%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13D/G 13F
Company
13D/G 13F
10%
$1,246,337,233
70,176,646 shares
 $0 31 Mar 2025
VANGUARD PORTFOLIO MANAGEMENT LLC
13D/G 13F
Vanguard Portfolio Management · Company
13D/G 13F
8.4%
$956,386,817
58,209,788 shares
 $0 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13D/G 13F
Vanguard Capital Management · Company
13D/G 13F
7.4%
$848,504,200
51,643,591 shares
 $0 31 Mar 2026
JPMORGAN CHASE & CO
13F 13D/G
Company
13F 13D/G
6.1%
from 13D/G
$740,307,008
44,731,541 shares
 — 31 Mar 2026
Thomas John T.
3/4/5
Director
3/4/5
0.12%
$13,637,441
830,033 shares
 +$24,730 29 May 2026
Tommy G. Thompson
3/4/5
Director
3/4/5
0.02%
$2,491,888
144,290 shares
 — 28 May 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
17
Shares
544,075
Rows available
17
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
752
Q2 2026 holders
17
Holder diff
-735
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .